Product Code: GVR-4-68040-663-0
U.S. Wound Debridement Market Summary
The U.S. wound debridement market size was valued at USD 1.53 billion in 2024 and is projected to reach USD 2.26 billion by 2033, growing at a CAGR of 4.3% from 2025 to 2033. The increasing prevalence of diabetes, obesity, and the growing number of traumatic injuries and chronic wounds continue to drive demand for advanced wound debridement solutions.
According to the CDC, approximately 129 million Americans live with at least one major chronic illness, and nearly 2% of the population suffers from chronic wounds, with incidence rising notably among older adults. These wounds, such as diabetic foot ulcers, pressure sores, and venous stasis ulcers, present significant clinical challenges and are associated with extended healing times, increased risk of complications, and substantial healthcare resource consumption.
On the regulatory and innovation front, U.S. federal agencies like the FDA are actively reshaping the landscape. The FDA has proposed reclassifying certain wound-care products-gels, creams, ointments, and liquid washes containing antimicrobials-into Class II or III devices, requiring more rigorous oversight through 510(k) notifications or premarket approvals (PMAs).
U.S. Wound Debridement Market Report Segmentation
This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. wound debridement market report based on product, method, wound type, mode of purchase, and end use:
- Product Outlook (Revenue, USD Million, 2021 - 2033)
- Gels
- Ointments & Creams
- Surgical Devices
- Medical Gauzes
- Ultrasonic Devices
- Others
- Method/Procedure Outlook (Revenue, USD Million, 2021 - 2033)
- Autolytic
- Enzymatic
- Surgical
- Mechanical
- Others
- Wound Type Outlook (Revenue, USD Million, 2021 - 2033)
- Pressure Ulcers
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Burn Wound
- Others
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals
- Homecare
- Others
- Mode of Purchase Outlook (Revenue, USD Million, 2021 - 2033)
- Prescription
- Over The Counter
- Others
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources
- 1.3.4. Primary Research
- 1.4. Information/Data Analysis
- 1.5. Market Formulation & Visualization
- 1.6. Data Validation & Publishing
- 1.7. Model Details
- 1.8. List of Secondary Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. U.S. Wound Debridement Market Variable Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market
- 3.1.2. Ancillary Market
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. U.S. Wound Debridement Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitution
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political & Legal landscape
- 3.3.2.2. Economic and Social landscape
- 3.3.2.3. Technological landscape
- 3.3.2.4. Environmental landscape
- 3.3.3. Regulatory Framework
Chapter 4. U.S. Wound Debridement Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. U.S. Wound Debridement Market: Product Movement Analysis
- 4.3. U.S. Wound Debridement Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
- 4.4. Gels
- 4.4.1. Gels Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5. Ointments & Creams
- 4.5.1. Ointments & Creams Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6. Surgical Devices
- 4.6.1. Surgical Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.7. Medical Gauzes
- 4.7.1. Medical Gauzes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.8. Ultrasonic Devices
- 4.8.1. Ultrasonic Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. U.S. Wound Debridement Market: Method/Procedures Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. U.S. Wound Debridement Market: Method/Procedures Movement Analysis
- 5.3. U.S. Wound Debridement Market Size & Trend Analysis, by Method/Procedures, 2021 to 2033 (USD Million)
- 5.4. Autolytic
- 5.4.1. Autolytic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.5. Enzymatic
- 5.5.1. Enzymatic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6. Surgical
- 5.6.1. Surgical Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.7. Mechanical
- 5.7.1. Mechanical Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.8. Others
- 5.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. U.S. Wound Debridement Market: Wound Type Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. U.S. Wound Debridement Market: Wound Type Movement Analysis
- 6.3. U.S. Wound Debridement Market Size & Trend Analysis, by Wound Type, 2021 to 2033 (USD Million)
- 6.4. Pressure Ulcers
- 6.4.1. Pressure Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5. Diabetic Foot Ulcers
- 6.5.1. Diabetic Foot Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6. Venous Leg Ulcers
- 6.6.1. Venous Leg Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.7. Burn Wound
- 6.7.1. Burn Wound Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.8. Others
- 6.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. U.S. Wound Debridement Market: By End Use Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. U.S. Wound Debridement Market: By End Use Movement Analysis
- 7.3. U.S. Wound Debridement Market Size & Trend Analysis, by End use, 2021 to 2033 (USD Million)
- 7.3.1. Hospitals
- 7.3.1.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.2. Homecare
- 7.3.2.1. Homecare Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.3. Others
- 7.3.3.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. U.S. Wound Debridement Market: By Mode of Purchase Estimates & Trend Analysis
- 8.1. Segment Dashboard
- 8.2. U.S. Wound Debridement Market: By Mode of Purchase Movement Analysis
- 8.3. U.S. Wound Debridement Market Size & Trend Analysis, by Mode of Purchase, 2021 to 2033 (USD Million)
- 8.3.1. Prescription
- 8.3.1.1. Prescription Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.2. Over the Counter
- 8.3.2.1. Over the Counter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.3. Others
- 8.3.3.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Market Participant Categorization
- 9.2. Company Market Position Analysis/ Heap Map Analysis
- 9.3. Company Profiles
- 9.3.1. Zimmer Biomet
- 9.3.1.1. Participant's Overview
- 9.3.1.2. Financial Performance
- 9.3.1.3. Product Benchmarking
- 9.3.1.4. Strategic Initiatives
- 9.3.2. Smith+Nephew
- 9.3.2.1. Participant's Overview
- 9.3.2.2. Financial Performance
- 9.3.2.3. Product Benchmarking
- 9.3.2.4. Strategic Initiatives
- 9.3.3. Coloplast Group
- 9.3.3.1. Participant's Overview
- 9.3.3.2. Financial Performance
- 9.3.3.3. Product Benchmarking
- 9.3.3.4. Strategic Initiatives
- 9.3.4. Convatec Group PLC
- 9.3.4.1. Participant's Overview
- 9.3.4.2. Financial Performance
- 9.3.4.3. Product Benchmarking
- 9.3.4.4. Strategic Initiatives
- 9.3.5. C. R. Bard
- 9.3.5.1. Participant's Overview
- 9.3.5.2. Financial Performance
- 9.3.5.3. Product Benchmarking
- 9.3.5.4. Strategic Initiatives
- 9.3.6. Lohmann & Rauscher
- 9.3.6.1. Participant's Overview
- 9.3.6.2. Financial Performance
- 9.3.6.3. Product Benchmarking
- 9.3.6.4. Strategic Initiatives